Clinical Trials in Phoenix

Showing 2941-2960 of 14,291 trials

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

NCT06673667

This is a first-in-human study to evaluate safety, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-621 in healthy male and female adult participants.

Healthy Participants Study

Kymera Therapeutics, Inc.118 participantsStarted Oct 2024

Phoenix, Arizona, United States • Lincoln, Nebraska, United States

RECRUITINGPhase 3< 1 mile

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

NCT05804370

This Phase 3 study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The study is planned to run for about 18 months with individual study participation lasting about two (2) weeks.

Ovarian Cancer

NX Development Corp170 participantsStarted May 2024

Phoenix, Arizona, United States • Annapolis, Maryland, United States • Baltimore, Maryland, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

NCT06176196

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Painful Lumbosacral Radiculopathy

Vertex Pharmaceuticals Incorporated218 participantsStarted Dec 2023

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Bakersfield, California, United States +51 more locations

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Find Trials by Condition in Phoenix

Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients